INNOVATIVE SYNDROMIC MOLECULAR DIAGNOSIS
After Pasteurian microbiology then PCR, Dendris offers the 3rd generation of diagnostics allowing the simultaneous identification of a wide panel of pathogens with high sensitivity and specificity.
Syndromic molecular biology
The syndromic approach aims to identify in a single analysis all the pathogens potentially responsible for a syndrome.
Backed by molecular biology, the identification of pathogens is done by their genotyping (DNA) instead of the phenotypic identification of microbiology.
Functionalizing the substrate with phosphorus dendrimers considerably enhances the sensitivity of our chip. Dendris has filed a patent on the Dendrimers surface chemistry process.
The machine-learning algorithm developed by Dendris delivers results from analyzed clinical samples automatically, reliably and fast.
The DendrisKIT DP is dedicated to the identification of 12 fungi involved in dermatophytosis.
CE-IVD markLearn more
Osteoarticular infections OA
The DendrisKIT OA allows the detection of 22 bacteria responsible for deep and osteoarticular infections, as well as the mecA resistance gene.
IR respiratory infections
The DendrisKIT IR panel makes it possible to identify in a single test the presence of 24 pathogens responsible for upper and lower respiratory infections.
In developmentLearn more
Invasive mycoses MI
The DendrisKIT MI is dedicated to the identification of targets involved in invasive pulmonary and blood mycoses.Learn more